Affiliation:
1. Chemical Resources Laboratory, Tokyo Institute of Technology, 4259 Nagatsuta, Midori-ku, Yokohama 226-8503, Japan
2. Mitsubishi Kagaku Institute of Life Sciences, 11 Minamiooya, Machida, Tokyo 194-8511, Japan
Abstract
ABSTRACT
Iturin A and its derivatives are lipopeptide antibiotics produced by
Bacillus subtilis
and several closely related bacteria. Three
iturin group operons (i.e., iturin A, mycosubtilin, and bacillomycin D) of those antibiotic-producing strains have been cloned and sequenced
thus far, strongly implying the horizontal transfer of these operons. To examine the nature of such horizontal transfer in terms of antibiotic production, a 42-kb region of the
B. subtilis
RB14 genome, which contains a complete 38-kb iturin A operon, was
transferred via competent cell transformation to the genome of a non-iturin A producer,
B. subtilis
168, using a method based on double-crossover homologous recombination with two short landing pad sequences (LPSs) in the genome. The recombinant was positively selected
by confirming the elimination of the
c
I repressor gene, which was localized between the two LPSs and substituted by the transferred
segment. The iturin A operon-transferred strain 168 was then converted into an iturin A producer by the introduction of an
sfp
gene,
which encodes 4′-phosphopantetheinyl transferase and is mutated in strain 168. By inserting the pleiotropic regulator
degQ
, the productivity of iturin A increased sevenfold and was restored to about half that of the donor strain RB14, without the transfer of
additional genes, such as regulatory or self-resistance genes.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献